skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,117  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Stockholders remove New Records: New From Last 3 Month remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Research in Focus: Gates MRI
Material Type:
Article
Add to My Research

Research in Focus: Gates MRI

The Lancet (British edition), 2024-03, Vol.403 (10432), p.1126-1126 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00580-4 ;PMID: 38522439

Full text available

2
iSpecimen (ISPC: 27.62c) jumps 5.0% on rising relative strength; +1.32c [5.0%] Vol Index 14.8 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

iSpecimen (ISPC: 27.62c) jumps 5.0% on rising relative strength; +1.32c [5.0%] Vol Index 14.8 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

3
iSpecimen (ISPC: 26.90c) plunges 7.6% weakening below moving average price; -2.2c [7.6%]
Material Type:
Newsletter Article
Add to My Research

iSpecimen (ISPC: 26.90c) plunges 7.6% weakening below moving average price; -2.2c [7.6%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 2, 2024

Digital Resources/Online E-Resources

4
iSpecimen (ISPC: 30.0c) soars 11% on rising relative strength; +3c [11.1%] Vol Index 1.2 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

iSpecimen (ISPC: 30.0c) soars 11% on rising relative strength; +3c [11.1%] Vol Index 1.2 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 30, 2024

Digital Resources/Online E-Resources

5
iSpecimen (ISPC: 26.60c) closes at 32% below VWAP; -1.42c [5.1%]
Material Type:
Newsletter Article
Add to My Research

iSpecimen (ISPC: 26.60c) closes at 32% below VWAP; -1.42c [5.1%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 27, 2024

Digital Resources/Online E-Resources

6
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
Material Type:
Newsletter Article
Add to My Research

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 9, 2024

Digital Resources/Online E-Resources

7
Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
Material Type:
Newsletter Article
Add to My Research

Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 9, 2024

Digital Resources/Online E-Resources

8
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Material Type:
Newsletter Article
Add to My Research

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 8, 2024

Digital Resources/Online E-Resources

9
Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting
Material Type:
Newsletter Article
Add to My Research

Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Mar 26, 2024

Digital Resources/Online E-Resources

10
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024
Material Type:
Newsletter Article
Add to My Research

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Mar 8, 2024

Digital Resources/Online E-Resources

11
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024
Material Type:
Newsletter Article
Add to My Research

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Mar 7, 2024

Digital Resources/Online E-Resources

12
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024
Material Type:
Newsletter Article
Add to My Research

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Mar 6, 2024

Digital Resources/Online E-Resources

13
iSpecimen (ISPC: 26.30c) keeps sliding, down 12% in 4 days; -3.6c [12.0%]
Material Type:
Newsletter Article
Add to My Research

iSpecimen (ISPC: 26.30c) keeps sliding, down 12% in 4 days; -3.6c [12.0%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

14
Vera Bradley (VRA: $6.84) drops 1.9%; -13c [1.9%]
Material Type:
Newsletter Article
Add to My Research

Vera Bradley (VRA: $6.84) drops 1.9%; -13c [1.9%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

15
Vera Bradley (VRA: $6.97) hits two-month high; +37c [5.6%]
Material Type:
Newsletter Article
Add to My Research

Vera Bradley (VRA: $6.97) hits two-month high; +37c [5.6%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 3, 2024

Digital Resources/Online E-Resources

16
iSpecimen (ISPC: 26.65c) keeps sliding, down 11% in 3 days; -3.25c [10.9%]
Material Type:
Newsletter Article
Add to My Research

iSpecimen (ISPC: 26.65c) keeps sliding, down 11% in 3 days; -3.25c [10.9%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 3, 2024

Digital Resources/Online E-Resources

17
Vera Bradley (VRA: $6.60) inches higher, resistance at 12-day EMA; +1c [0.2%]
Material Type:
Newsletter Article
Add to My Research

Vera Bradley (VRA: $6.60) inches higher, resistance at 12-day EMA; +1c [0.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 2, 2024

Digital Resources/Online E-Resources

18
Vera Bradley (VRA: $6.59) falls 2.8%; -19c [2.8%]
Material Type:
Newsletter Article
Add to My Research

Vera Bradley (VRA: $6.59) falls 2.8%; -19c [2.8%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 1, 2024

Digital Resources/Online E-Resources

19
iSpecimen (ISPC: 29.10c) falls 2.7%; -0.8c [2.7%]
Material Type:
Newsletter Article
Add to My Research

iSpecimen (ISPC: 29.10c) falls 2.7%; -0.8c [2.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 1, 2024

Digital Resources/Online E-Resources

20
Vera Bradley (VRA: $6.76) rises in 4 out of last 5 days, 5-day rise of 5.1%; +1.5c [0.2%]
Material Type:
Newsletter Article
Add to My Research

Vera Bradley (VRA: $6.76) rises in 4 out of last 5 days, 5-day rise of 5.1%; +1.5c [0.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 30, 2024

Digital Resources/Online E-Resources

Results 1 - 20 of 1,117  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait